Hives Treatments
Find Hives Treatments
Medications for Hives
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Hives.
Found 18 Approved Drugs for Hives
Danazol
Generic Name
Danazol
Danazol
Generic Name
Danazol
Form: Capsule
Method of administration: Oral
FDA approval date: August 09, 1996
Classification: Androgen
Endometriosis. Danazol capsules are indicated for the treatment of endometriosis amenable to hormonal management. Hereditary Angioedema. Danazol capsules are indicated for the prevention of attacks of angioedema of all types (cutaneous, abdominal, laryngeal) in males and females.
Icatibant
Brand Names
Firazyr, Sajazir
Icatibant
Brand Names
Firazyr, Sajazir
Form: Injection
Method of administration: Subcutaneous
FDA approval date: August 25, 2011
Classification: Bradykinin B2 Receptor Antagonist
FIRAZYR ® (icatibant) is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older. FIRAZYR is a bradykinin B2 receptor antagonist indicated for treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older. ( 1 )
Lisinopril
Brand Names
Qbrelis, Zestoretic, Zestril
Lisinopril
Brand Names
Qbrelis, Zestoretic, Zestril
Form: Tablet, Solution
Method of administration: Oral
FDA approval date: July 01, 2002
Classification: Angiotensin Converting Enzyme Inhibitor
QBRELIS is an angiotensin converting enzyme (ACE) inhibitor indicated for: Treatment of hypertension in adults and pediatric patients 6 years of age and older.
Pamoate
Generic Name
Pamoate
Pamoate
Generic Name
Pamoate
Form: Capsule
Method of administration: Oral
FDA approval date: December 14, 1981
Classification: Antihistamine
For symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested. Useful in the management of pruritus due to allergic conditions such as chronic urticaria and atopic and contact dermatoses, and in histamine-mediated pruritus. As a sedative when used as premedication and following general anesthesia, hydroxyzine may potentiate meperidine (Demerol ® ) and barbiturates, so their use in pre-anesthetic adjunctive therapy should be modified on an individual basis. Atropine and other belladonna alkaloids are not affected by the drug. Hydroxyzine is not known to interfere with the action of digitalis in any way and it may be used concurrently with this agent. The effectiveness of hydroxyzine as an antianxiety agent for long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should reassess periodically the usefulness of the drug for the individual patient.
Dupixent
Generic Name
Dupilumab
Dupixent
Generic Name
Dupilumab
Form: Injection
Method of administration: Subcutaneous
FDA approval date: March 28, 2017
Classification: Interleukin-4 Receptor alpha Antagonist
DUPIXENT is an interleukin-4 receptor alpha antagonist indicated: Atopic Dermatitis for the treatment of adult and pediatric patients aged 6 months and older with moderate-to-severe AD whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. DUPIXENT can be used with or without topical corticosteroids.
Showing 1-5 of 18
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances